These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


257 related items for PubMed ID: 4253575

  • 1. [Therapeutic possibilities in spasticity. Review].
    Roşianu C.
    Neurol Psihiatr Neurochir; 1971; 16(1):59-70. PubMed ID: 4253575
    [No Abstract] [Full Text] [Related]

  • 2. [Therapy of spastic syndromes].
    Hartmann-von Monakow K.
    Bibl Psychiatr Neurol; 1969; 139():114-23. PubMed ID: 4257720
    [No Abstract] [Full Text] [Related]

  • 3. [Neuroleptics, thymoleptics and tranquilizers in neurological therapy].
    Hertrich O.
    Bibl Psychiatr Neurol; 1969; 139():88-113. PubMed ID: 4400242
    [No Abstract] [Full Text] [Related]

  • 4. [MEDICAL TREATMENT OF SPASTICITY].
    PEDERSEN E.
    Nord Med; 1964 Jan 02; 71():17-20. PubMed ID: 14103689
    [No Abstract] [Full Text] [Related]

  • 5. [Problems of psychopharmacology in neurosurgery].
    Lobova LP, Dobrokhotova TA, Mashanova GA, Fedorov SN.
    Vopr Neirokhir; 1967 Jan 02; 31(2):47-51. PubMed ID: 5590597
    [No Abstract] [Full Text] [Related]

  • 6. The use of drugs in the treatment of spasticity.
    Lenman JA.
    Proc R Soc Med; 1970 Sep 02; 63(9):935-7. PubMed ID: 5477076
    [No Abstract] [Full Text] [Related]

  • 7. [Comparison of the characteristics of the effect of tranquilizing agents under experimental and clinical conditions].
    Vikhliaev IuI, Klygul' TA, Prokudin VN, Adronati SA.
    Farmakol Toksikol; 1971 Sep 02; 34(1):30-5. PubMed ID: 5563373
    [No Abstract] [Full Text] [Related]

  • 8. [Psychotropic therapy and intraocular pressure].
    Gol'dovskaia IL.
    Oftalmol Zh; 1975 Sep 02; 30(1):70-4. PubMed ID: 235106
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of myotonic dystrophy].
    Uono M.
    Naika; 1970 Apr 02; 25(4):664-8. PubMed ID: 4317890
    [No Abstract] [Full Text] [Related]

  • 10. [The basic criteria for clinical evaluation of the effect of tranquilizers].
    Aleksandrovskiĭ IuA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 Apr 02; 70(12):1873-82. PubMed ID: 5511527
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A REVIEW OF PHARMACOLOGIC AGENTS USED IN A PHYSICAL MEDICINE AND REHABILITATION SETTING.
    FORSTER S, BENTON JG.
    Arch Phys Med Rehabil; 1964 Jun 02; 45():277-82. PubMed ID: 14154804
    [No Abstract] [Full Text] [Related]

  • 19. [Statistical reports of the psychopharmacological agents used in the past 10 years in the Ospedale Neuropsichiatrico Provinciale of Mantua].
    Castelli G, Nardini L.
    Riv Sper Freniatr Med Leg Alien Ment; 1967 Oct 31; 91(5):1288-99. PubMed ID: 5608979
    [No Abstract] [Full Text] [Related]

  • 20. Drugs in dentistry. Muscle relaxants.
    Ciancio SG.
    Dent Manage; 1985 Dec 31; 25(12):56, 59-60. PubMed ID: 3866707
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.